Hopefully with Trump looking at speeding up FDA or allowing patients to access trials more readily, time for Viralytics to apply to FDA for approval.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game